'Personalised medicine' is accelerating in clinical interventions (e.g. in genomics, pharmaceuticals, surgical implants and synthetic organoids). Now it's time to think about 'personalised medicine' in terms of the data we use to make clinical decisions and measure outcomes.

Transparency around AI is the first step to building trust, but we still have some way to go to earning that trust in medical AI.

Hardian supported Koios Medical to help their CEO Chad and this American team to navigate the minefield that is EU medical device regulation, and gain a footing here in Europe with a Class IIa CE mark.

The worst person you can fool about your product’s value is yourself. It’s time to take a reality check on the feasibility and risks of your grand idea.

How do you build an AI company in healthcare? What can AI in radiology actually do? What should it be doing? Are clinicians ever going to be replaced? What does the future look like in healthcare AI?

In this HS Health Tech podcast, James is joined by Dr. Hugh Harvey, Managing Director at Hardian Health.